Being selected as one of the finalist for the Achema Gründerpreis, mk2 Biotechnologies attended this year’s Achema World Forum in Frankfurt and presented at a booth and in an oral presentation the advantages of its superior peptide synthesis technology. In several discussions with experts and enthusiasts mk2 Biotechnologies underlined its [...]
mk2 Biotechnologies participated as emerging startup at the BioVaria 2018 in Munich, Germany. The oral and poster presentations catalyzed fruitful discussions with technology experts from industry and finance underlining the importance of new peptide synthesis technologies.
mk2 Biotechnologies is supported by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology through the funding program FLÜGGE. The competent jury considered the innovative peptide synthesis technology by mk2 Biotechnologies to provide outstanding opportunities for several applications. The technological advances of simultaneous high purities, authentic amino [...]
